GUARDIAN the world's first and only heart attack warning system

The world's first and only heart attack warning system

The GUARDIAN is uniquely positioned in the cardiac monitoring market. It is the only product with the ability to detect acute coronary syndrome events (including heart attack) in real-time and alert the patient, even in the absence of symptoms.

The GUARDIAN monitor’s the heart’s electrical activity 24 hours a day, 7 days a week. In addition to detecting and alerting the patient of an ACS event (STEMI and Non-STEMI events), this 24/7 monitoring enables the GUARDIAN to assist in diagnosing other cardiac-related medical conditions1 as shown in the table below.

The Guardian, not like a pacemaker | Talk to Hydrix

The GUARDIAN device fills an unmet medical need by providing more effective diagnosis of a life-threatening condition when compared to patient symptoms alone

FDA Summary of Safety and Effectiveness Data (SSED) on file at Hydrix

References

1. Gibson, M., Holmes, D., Mikdadi, G., et al. Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction. JACC. 2019; 73(15):1919-1927.

The GUARDIAN is not available for supply in Australia and is currently not included on the Australian Register of Therapeutic Goods.